136 related articles for article (PubMed ID: 37526313)
1. Insights into product and process related challenges of lentiviral vector bioprocessing.
Perry C; Mujahid N; Takeuchi Y; Rayat ACME
Biotechnol Bioeng; 2023 Aug; ():. PubMed ID: 37526313
[TBL] [Abstract][Full Text] [Related]
2. Development of Large-Scale Downstream Processing for Lentiviral Vectors.
Valkama AJ; Oruetxebarria I; Lipponen EM; Leinonen HM; Käyhty P; Hynynen H; Turkki V; Malinen J; Miinalainen T; Heikura T; Parker NR; Ylä-Herttuala S; Lesch HP
Mol Ther Methods Clin Dev; 2020 Jun; 17():717-730. PubMed ID: 32346549
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
4. Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene Delivery.
Rosales Gerpe MC; van Lieshout LP; Domm JM; van Vloten JP; Datu J; Ingrao JC; Yu DL; de Jong J; Moraes TJ; Krell PJ; Bridle BW; Wootton SK
Hum Gene Ther; 2020 Apr; 31(7-8):459-471. PubMed ID: 32000531
[TBL] [Abstract][Full Text] [Related]
5. Pseudotyped Lentiviral Vectors: One Vector, Many Guises.
Joglekar AV; Sandoval S
Hum Gene Ther Methods; 2017 Dec; 28(6):291-301. PubMed ID: 28870117
[TBL] [Abstract][Full Text] [Related]
6. Generation of High-Titer Pseudotyped Lentiviral Vectors.
Hu S; Li M; Akkina R
Methods Mol Biol; 2019; 1937():125-134. PubMed ID: 30706393
[TBL] [Abstract][Full Text] [Related]
7. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
8. Depth filtration for clarification of intensified lentiviral vector suspension cell culture.
Mayani M; Nellimarla S; Mangalathillam R; Rao H; Patarroyo-White S; Ma J; Figueroa B
Biotechnol Prog; 2024; 40(2):e3409. PubMed ID: 37985144
[TBL] [Abstract][Full Text] [Related]
9. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
[TBL] [Abstract][Full Text] [Related]
10. Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes.
Tomás HA; Mestre DA; Rodrigues AF; Guerreiro MR; Carrondo MJT; Coroadinha AS
Mol Ther Methods Clin Dev; 2019 Dec; 15():1-8. PubMed ID: 31528654
[TBL] [Abstract][Full Text] [Related]
11. Downstream processing of lentiviral vectors: releasing bottlenecks.
Bandeira V; Peixoto C; Rodrigues AF; Cruz PE; Alves PM; Coroadinha AS; Carrondo MJ
Hum Gene Ther Methods; 2012 Aug; 23(4):255-63. PubMed ID: 22934827
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Conditioning and Lentiviral Vector Pseudotype on Short- and Long-Term Airway Reporter Gene Expression in Mice.
Carpentieri C; Farrow N; Cmielewski P; Rout-Pitt N; McCarron A; Knight E; Parsons D; Donnelley M
Hum Gene Ther; 2021 Aug; 32(15-16):817-827. PubMed ID: 33947249
[TBL] [Abstract][Full Text] [Related]
13. A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.
Marino MP; Panigaj M; Ou W; Manirarora J; Wei CH; Reiser J
Gene Ther; 2015 Mar; 22(3):280-5. PubMed ID: 25608718
[TBL] [Abstract][Full Text] [Related]
14. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
[TBL] [Abstract][Full Text] [Related]
15. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
16. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
[TBL] [Abstract][Full Text] [Related]
17. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vector determinants of anion-exchange chromatography elution heterogeneity.
Pamenter G; Davies L; Lamont C; Rahim D; Knevelman C; Miskin J; Mitrophanous K; Dikicioglu D; Bracewell DG
Biotechnol Bioeng; 2024 Jun; ():. PubMed ID: 38874319
[TBL] [Abstract][Full Text] [Related]
19. Design and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor-overexpressed cancer cells: Developing a new retargeting system for lentivirus vectors.
Ebrahimabadi S; Shahbazi M; Akbari M; Golalipour M; Farazmandfar T
J Gene Med; 2019 Jun; 21(6):e3095. PubMed ID: 31050357
[TBL] [Abstract][Full Text] [Related]
20. Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.
Eleftheriadou I; Dieringer M; Poh XY; Sanchez-Garrido J; Gao Y; Sgourou A; Simmons LE; Mazarakis ND
Biomaterials; 2017 Apr; 123():1-14. PubMed ID: 28152379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
